Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5464933 | ROCHE | Synthetic peptide inhibitors of HIV transmission |
Jun, 2013
(10 years ago) | |
US6133418 | ROCHE | Synthetic peptide inhibitors of HIV transmission |
Nov, 2014
(9 years ago) | |
US6475491 | ROCHE | Treatment of HIV and other viral infections using combinatorial therapy |
Jun, 2015
(8 years ago) |
Market Authorisation Date: 13 March, 2003
Treatment: Treatment of hiv
Dosage: INJECTABLE;SUBCUTANEOUS